Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
MEDVi operates on a cash-pay model only
Clinical Trial Findings Recent studies have shown phenomenal outcomes
More recent outcomes data suggests potential reductions in major adverse cardiovascular events among high-risk populations, further broadening interest in the downstream health implications of sustained GLP-1 drug use
Interestingly, when mediation analysis was performed to investigate further what factors may have contributed to the reduced risk of developing new OSA, only 22% of the lower risk was attributable to combined changes in conventional risk factors (with the majority being due to weight reduction)
For those new to self-injection, resources on how to inject semaglutide properly and choosing the best injection sites are essential reading
